<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37978203</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>06</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1476-5489</ISSN><JournalIssue CitedMedium="Internet"><Volume>36</Volume><Issue>6</Issue><PubDate><Year>2024</Year><Month>Sep</Month></PubDate></JournalIssue><Title>International journal of impotence research</Title><ISOAbbreviation>Int J Impot Res</ISOAbbreviation></Journal><ArticleTitle>Post-infection erectile dysfunction risk - comparing COVID-19 with other common acute viral infections: a large national claims database analysis.</ArticleTitle><Pagination><StartPage>607</StartPage><EndPage>613</EndPage><MedlinePgn>607-613</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41443-023-00794-2</ELocationID><Abstract><AbstractText>It is unknown if the risk of erectile dysfunction (ED) following Coronavirus-19 (COVID-19) infection is virus-specific. Our study assessed the risk of ED in COVID-19 patients as compared to patients with other common viral infections. The TriNetX COVID-19 Research Network was queried. We examined cohorts of men aged ≥18 years infected with: COVID-19, influenza, respiratory syncytial virus, enterovirus, acute viral hepatitis, mononucleosis, and herpes zoster. Men were included if they had at least one outpatient follow-up visit within 18 months and excluded if they had one of the other viruses of interest or a prior ED diagnosis or treatment, prostatectomy, pelvis radiation, or chronic hepatitis infection. Cohorts were propensity score matched and compared for differences in new ED diagnosis and/or prescription of phosphodiesterase-5 inhibitors (PDE5i). COVID-19 positive men were less likely to develop ED or have a PDE5i prescription than men with infected with herpes zoster [Relative Risk (RR): 0.37, 95% Confidence Interval (CI) 0.27-0.49] and more likely to develop ED or have a PDE5i prescription than men with no acute viral illness (RR: 1.33, 95% CI 1.25-1.42). In this national propensity-matched cohort study comparing post-infection ED risk and PDE5i prescriptions, we found that COVID-19 was no more likely to result in a diagnosis of ED or prescription of PDE5i when compared to all acute viral illnesses except herpes zoster, which was more likely to result in a diagnosis of ED or prescription of PDE5i when compared to COVID-19. These findings suggest an inflammatory etiology (perhaps due to cytokine release, endothelial dysfunction, or blunted hormone signaling) behind any acute infection can result in a heightened ED risk; however, further studies are required to investigate the connection between other viral infections and ED.</AbstractText><CopyrightInformation>© 2023. The Author(s), under exclusive licence to Springer Nature Limited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Una E</ForeName><Initials>UE</Initials><Identifier Source="ORCID">0000-0002-2406-2594</Identifier><AffiliationInfo><Affiliation>The James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Able</LastName><ForeName>Corey</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Urology, Division of Surgery, The University of Texas Medical Branch, Galveston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grutman</LastName><ForeName>Aurora J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>The James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maremanda</LastName><ForeName>Ankith P</ForeName><Initials>AP</Initials><AffiliationInfo><Affiliation>The James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nicholson</LastName><ForeName>Ryan C</ForeName><Initials>RC</Initials><Identifier Source="ORCID">0000-0003-4218-3696</Identifier><AffiliationInfo><Affiliation>The James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gabrielson</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>The James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kohn</LastName><ForeName>Taylor P</ForeName><Initials>TP</Initials><AffiliationInfo><Affiliation>The James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA. tkohn2@jhmi.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>11</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Int J Impot Res</MedlineTA><NlmUniqueID>9007383</NlmUniqueID><ISSNLinking>0955-9930</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D058986">Phosphodiesterase 5 Inhibitors</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007172" MajorTopicYN="Y">Erectile Dysfunction</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="Y">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058986" MajorTopicYN="N">Phosphodiesterase 5 Inhibitors</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014777" MajorTopicYN="N">Virus Diseases</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057216" MajorTopicYN="N">Propensity Score</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>8</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>11</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>10</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>6</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>11</Month><Day>18</Day><Hour>11</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>11</Month><Day>18</Day><Hour>0</Hour><Minute>12</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37978203</ArticleId><ArticleId IdType="doi">10.1038/s41443-023-00794-2</ArticleId><ArticleId IdType="pii">10.1038/s41443-023-00794-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ziegler CGK, Allon SJ, Nyquist SK, Mbano IM, Miao VN, Tzouanas CN, et al. SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues. Cell. 2020;181:1016–1035.e19. https://doi.org/10.1016/j.cell.2020.04.035</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.04.035</ArticleId><ArticleId IdType="pubmed">32413319</ArticleId><ArticleId IdType="pmc">7252096</ArticleId></ArticleIdList></Reference><Reference><Citation>Nägele MP, Haubner B, Tanner FC, Ruschitzka F, Flammer AJ. Endothelial dysfunction in COVID-19: Current findings and therapeutic implications. Atherosclerosis. 2020;314:58–62. https://doi.org/10.1016/j.atherosclerosis.2020.10.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.atherosclerosis.2020.10.014</ArticleId><ArticleId IdType="pubmed">33161318</ArticleId><ArticleId IdType="pmc">7554490</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu KY, Nackeeran S, Horodyski L, Masterson TA, Ramasamy R. COVID-19 infection is associated with new onset erectile dysfunction: insights from a national registry. Sex Med. 2022;10:100478 https://doi.org/10.1016/j.esxm.2021.100478</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.esxm.2021.100478</ArticleId><ArticleId IdType="pubmed">34931145</ArticleId></ArticleIdList></Reference><Reference><Citation>Hebert KJ, Matta R, Horns JJ, Paudel N, Das R, McCormick BJ, et al. Prior COVID-19 infection associated with increased risk of newly diagnosed erectile dysfunction. Int J Impot Res. 2023:1–5. https://doi.org/10.1038/s41443-023-00687-4</Citation></Reference><Reference><Citation>Nassau DE, Best JC, Kresch E, Gonzalez DC, Khodamoradi K, Ramasamy R. Impact of the SARS-CoV-2 virus on male reproductive health. BJU Int. 2022;129:143–50. https://doi.org/10.1111/bju.15573</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bju.15573</ArticleId><ArticleId IdType="pubmed">34402155</ArticleId></ArticleIdList></Reference><Reference><Citation>Sansone A, Mollaioli D, Ciocca G, Limoncin E, Colonnello E, Vena W, et al. Addressing male sexual and reproductive health in the wake of COVID-19 outbreak. J Endocrinol Invest. 2021;44:223–31. https://doi.org/10.1007/s40618-020-01350-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40618-020-01350-1</ArticleId><ArticleId IdType="pubmed">32661947</ArticleId></ArticleIdList></Reference><Reference><Citation>Fusco F, D’Anzeo G, Rossi A, Sciorio C, Buonomo AR, d’Emmanuele di Villa Bianca R, et al. Erectile dysfunction in patients with chronic viral hepatitis: a systematic review of the literature. Expert Opin Pharmacother. 2013;14:2533–44. https://doi.org/10.1517/14656566.2013.850073</Citation><ArticleIdList><ArticleId IdType="doi">10.1517/14656566.2013.850073</ArticleId><ArticleId IdType="pubmed">24215104</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein RS, Lo Y, Santoro N, Dobs AS. Androgen levels in older men who have or who are at risk of acquiring HIV infection. Clin Infect Dis Publ Infect Dis Soc Am. 2005;41:1794–803. https://doi.org/10.1086/498311</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/498311</ArticleId></ArticleIdList></Reference><Reference><Citation>Mäkelä S, Jaatinen P, Miettinen M, Salmi J, Ala-Houhala I, Huhtala H, et al. Hormonal deficiencies during and after Puumala hantavirus infection. Eur J Clin Microbiol Infect Dis. 2010;29:705–13. https://doi.org/10.1007/s10096-010-0918-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10096-010-0918-y</ArticleId><ArticleId IdType="pubmed">20397036</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J, Kim BE, Leung DYM. Pathophysiology of atopic dermatitis: clinical implications. Allergy Asthma Proc. 2019;40:84–92. https://doi.org/10.2500/aap.2019.40.4202</Citation><ArticleIdList><ArticleId IdType="doi">10.2500/aap.2019.40.4202</ArticleId><ArticleId IdType="pubmed">30819278</ArticleId><ArticleId IdType="pmc">6399565</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaynar M, Gomes ALQ, Sokolakis I, Gül M. Tip of the iceberg: erectile dysfunction and COVID-19. Int J Impot Res. 2022;34:152–7. https://doi.org/10.1038/s41443-022-00540-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41443-022-00540-0</ArticleId><ArticleId IdType="pubmed">35152276</ArticleId><ArticleId IdType="pmc">8853253</ArticleId></ArticleIdList></Reference><Reference><Citation>Kresch E, Achua J, Saltzman R, Khodamoradi K, Arora H, Ibrahim E, et al. COVID-19 endothelial dysfunction can cause erectile dysfunction: histopathological, immunohistochemical, and ultrastructural study of the human penis. World J Mens Health. 2021;39:466–9. https://doi.org/10.5534/wjmh.210055</Citation><ArticleIdList><ArticleId IdType="doi">10.5534/wjmh.210055</ArticleId><ArticleId IdType="pubmed">33988001</ArticleId><ArticleId IdType="pmc">8255400</ArticleId></ArticleIdList></Reference><Reference><Citation>Golan R, Muthigi A, Ramasamy R. Pro: does COVID affect male reproductive health? J Urol. 2022;208:786–7. https://doi.org/10.1097/JU.0000000000002846</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/JU.0000000000002846</ArticleId><ArticleId IdType="pubmed">35830551</ArticleId></ArticleIdList></Reference><Reference><Citation>Pons S, Fodil S, Azoulay E, Zafrani L. The vascular endothelium: the cornerstone of organ dysfunction in severe SARS-CoV-2 infection. Crit Care. 2020;24:353 https://doi.org/10.1186/s13054-020-03062-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-03062-7</ArticleId><ArticleId IdType="pubmed">32546188</ArticleId><ArticleId IdType="pmc">7296907</ArticleId></ArticleIdList></Reference><Reference><Citation>Marchenko V, Zelinskaya I, Toropova Y, Shmakova T, Podyacheva E, Lioznov D, et al. Influenza A virus causes histopathological changes and impairment in functional activity of blood vessels in different vascular beds. Viruses. 2022;14:396 https://doi.org/10.3390/v14020396</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14020396</ArticleId><ArticleId IdType="pubmed">35215989</ArticleId><ArticleId IdType="pmc">8874985</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee CG, Yoon HJ, Zhu Z, Link H, Wang Z, Galtney JM, et al. Respiratory syncytial virus stimulation of vascular endothelial cell growth Factor/Vascular permeability factor. Am J Respir Cell Mol Biol. 2000;23:662–9. https://doi.org/10.1165/ajrcmb.23.5.4188</Citation><ArticleIdList><ArticleId IdType="doi">10.1165/ajrcmb.23.5.4188</ArticleId><ArticleId IdType="pubmed">11062145</ArticleId></ArticleIdList></Reference><Reference><Citation>Madjid M, Aboshady I, Awan I, Litovsky S, Casscells SW. Influenza and cardiovascular disease: is there a causal relationship? Tex Heart Inst J. 2004;31:4–13.</Citation><ArticleIdList><ArticleId IdType="pubmed">15061620</ArticleId><ArticleId IdType="pmc">387426</ArticleId></ArticleIdList></Reference><Reference><Citation>Paudel V. Erectile dysfunction secondary to herpes zoster. J Nepal Health Res Counc. 2020;17:556–7. https://doi.org/10.33314/jnhrc.v17i4.2174</Citation><ArticleIdList><ArticleId IdType="doi">10.33314/jnhrc.v17i4.2174</ArticleId><ArticleId IdType="pubmed">32001867</ArticleId></ArticleIdList></Reference><Reference><Citation>Rix GH, Carroll DN, MacFarlane JR. Herpes zoster producing temporary erectile dysfunction. Int J Impot Res. 2001;13:352–3. https://doi.org/10.1038/sj.ijir.3900786</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.ijir.3900786</ArticleId><ArticleId IdType="pubmed">11918252</ArticleId></ArticleIdList></Reference><Reference><Citation>Erol B, Avci A, Eken C, Ozgok Y. Urinary retention, erectile dysfunction and meningitis due to sacral herpes zoster: a case report and review of the literature. Urol Int. 2009;82:238–41. https://doi.org/10.1159/000200807</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000200807</ArticleId><ArticleId IdType="pubmed">19322017</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim M, Kim SY, Rou WS, Hwang SW, Lee BS. Erectile dysfunction in patients with liver disease related to chronic hepatitis B. Clin Mol Hepatol. 2015;21:352–7. https://doi.org/10.3350/cmh.2015.21.4.352</Citation><ArticleIdList><ArticleId IdType="doi">10.3350/cmh.2015.21.4.352</ArticleId><ArticleId IdType="pubmed">26770923</ArticleId><ArticleId IdType="pmc">4712162</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Z, Jiang C, Cheng X, Ma L, Xin Y, Liu T, et al. Secondary hypogonadism following hand, foot, and mouth disease in an adult: a case report and review of literature. BMC Infect Dis. 2022;22:56 https://doi.org/10.1186/s12879-022-07030-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-022-07030-0</ArticleId><ArticleId IdType="pubmed">35033020</ArticleId><ArticleId IdType="pmc">8760742</ArticleId></ArticleIdList></Reference><Reference><Citation>Hutt-Fletcher LM. The long and complicated relationship between epstein-barr virus and epithelial cells. J Virol. 2017;91:e01677–16. https://doi.org/10.1128/JVI.01677-16</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01677-16</ArticleId><ArticleId IdType="pubmed">27795426</ArticleId></ArticleIdList></Reference><Reference><Citation>DeLay KJ, Haney N, Hellstrom WJ. Modifying risk factors in the management of erectile dysfunction: a review. World J Mens Health. 2016;34:89–100. https://doi.org/10.5534/wjmh.2016.34.2.89</Citation><ArticleIdList><ArticleId IdType="doi">10.5534/wjmh.2016.34.2.89</ArticleId><ArticleId IdType="pubmed">27574592</ArticleId><ArticleId IdType="pmc">4999494</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>